Sentences with phrase «person skilled in the art»

Courts, however, generally require the expert evidence of persons skilled in the art....

The Federal Circuit reviewed the conflicting expert testimony Teva and Sandoz presented to the trial court on whether persons skilled in the art would understand the term «molecular weight.»

«(a) Identify the notional person skilled in the art; (b) Identify the relevant common general knowledge of that person;

In addition, the patent must provide enough description to allow a person skilled in the art to reproduce the invention.

In the patent application, the invention must be presented in such a way that a diverse audience, ranging from a person skilled in the arts to a judge with no scientific background, can understand it.

Abbott's evidence was that a person skilled in the art was «well aware that antibodies did not need to be identical to bind to the same cytokine or treat the same disease».

In some ways the notional «person skilled in the art» (who by definition is not inventive) is expected to know more, and earlier, than the inventors themselves (who are obviously inventive).

That is, can you describe your invention / idea in sufficient detail such that a person skilled in the art could make and use it?

The FC has also explicitly recognized that it is the person skilled in the art who needed to be able to «make the leap to predict use of the compound in humans».

For example, courts regularly accept testimony from expert and fact witnesses (including the inventors) concerning such matters as the background science, the operation of the invention, and the patent's significance to persons skilled in the art.

Applying this framework to the case on appeal, the Court held that the district court's fact finding that a person skilled in the art would not have considered «molecular weight» ambiguous was entitled to deference.

Finally, Teva may lead to a subtle refocussing of the claim construction process on the factual question whether a disputed term in a claim had a particular meaning to a person skilled in the art at the relevant time.

(4) Viewed without any knowledge of the alleged invention as claimed, do those differences constitute steps which would have been obvious to the person skilled in the art or do they require any degree of invention?

No matter the approach, parties should carefully consider the claim language, the patent as a whole, the state of the art, the person skilled in the art and work with their experts to get their facts and arguments before the court.

In my view, those references to the inventor's intention refer to an objective manifestation of that intent in the patent claims, as interpreted by the person skilled in the art, and do not contemplate extrinsic evidence such as statements or admissions made in the course of patent prosecution.

Instead of looking to the patent file history, the claim term was analyzed by the court from the perspective of the person skilled in the art looking only at the patent (but not the prosecution history).

The in vivo studies were applied as evidence that a person skilled in the art would have considered it likely that the techniques disclosed in the references cited in the petition and institution decision would be successful in animals.

During the trial, Genzyme argued that the claimed inventions were not obvious in light of the references, because all the references cited in the petition and decision to institute described in vitro experiments and a person skilled in the art would not have considered it likely that the results would be successful in live animals.

The person skilled in the art has to show the same invention is «plain as day» 10 years earlier.

A patentee is able to clarify the definition of his invention and how to make it, so the person skilled in the art can make it successfully, by narrowing its claims (and arguably selecting its best compounds from the thousands it may have initially started with at filing).

The four - step approach to obviousness adopted by the Court is as follows: (1)(a) Identify the notional «person skilled in the art»; (b) Identify the relevant common general knowledge of that person; (2) Identify the inventive concept of the claim in question or if that can not readily be done, construe it; (3) Identify what, if any, difference exists between the matter cited as... [more]

At the same time, the person skilled in the art was required to have determined in 1987 that it was «plain as day» that this one compound (as eventually selected to be claimed by the patentee) would be useful for the claimed uses.

This leads to the finding that, had there been only 1 compound claim, the person skilled in the art would not be guessing and would be able to use the invention successfully because they would know the «real compound» must be the specific claimed compound.

This admittedly strained analysis arises because the SCC took the rather novel approach of reviewing Pfizer's Viagra patent by considering whether the person skilled in the art could determine what the «real compound» was that Pfizer had successfully tested and described anonymously in its patent.

The SCC looked at 2 different compound claims and found the person skilled in the art would be unable to identify the «real compound».

An important quid pro quo for a patent, is the disclosure of the details of the innovation sufficient that a person skilled in the art can take advantage of the invention.

Otherwise the person skilled in the art is permitted to rely on external public literature / documents at the time of filing that may not be self - evident to evaluate whether a prediction is sound (ie beyond the common general knowledge type of searches that a person skilled in the art is readily able to do for evaluating obviousness)?

Otherwise there would be no need to evaluate the necessary level of disclosure in a patent / whether to also consider the knowledge of the person skilled in the art.

The Federal Court of Appeal's finding that what is self - evident to a person skilled in the art need not be in the patent [5](a somewhat common sense approach adopting earlier FCA jurisprudence in Eurocopter, 2013 FCA 261) signals tacit continuing approval of the disclosure requirement.

the specification of the patent does not disclose the invention sufficiently clearly and completely for it to be carried out by a person skilled in the art («insufficiency»), and